Compare Stocks

→ Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (From GoldenCrest Metals) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BCTX BriaCell Therapeutics	$2.19 -5.6%	$2.86	$2.01 ▼ $7.59	$35.00M	1.02	90,171 shs	22,528 shs
COT Cotinga Pharmaceuticals Inc. (COT.V)	C$0.04 -41.7%	C$0.03	C$0.02 ▼ C$0.12	C$770K	N/A	20,281 shs	1,000 shs
MTFB MOTIF BIO PLC/S	$0.11	$0.10	$0.08 ▼ $11.50	N/A	N/A	N/A	867,698 shs
PBS Invesco Next Gen Media and Gaming ETF	$41.36 -0.2%	$42.04	$30.95 ▼ $40.10	$29.78M	1.38	5,287 shs	424 shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BCTX BriaCell Therapeutics	+5.45%	+3.11%	-7.94%	-40.51%	-67.51%
COT Cotinga Pharmaceuticals Inc. (COT.V)	0.00%	0.00%	0.00%	0.00%	0.00%
MTFB MOTIF BIO PLC/S	0.00%	0.00%	0.00%	0.00%	0.00%
PBS Invesco Next Gen Media and Gaming ETF	0.00%	-3.46%	-7.57%	+0.36%	+17.58%

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BCTX BriaCell Therapeutics	1.3946 of 5 stars	3.5	4.0	0.0	0.0	0.0	1.7	0.0
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BCTX BriaCell Therapeutics	3.00	Buy	$18.00	721.92% Upside
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	0.00	N/A	$47.82	15.63% Upside

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BCTX BriaCell Therapeutics	N/A	N/A	N/A	N/A	($0.24) per share	N/A
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	C$0.00 per share	17.50	C($0.18) per share	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BCTX BriaCell Therapeutics	-$20.30M	-$1.68	N/A	N/A	N/A	N/A	N/A	-57.48%	6/12/2024 (Estimated)
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	-C$0.12	N/A	∞	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	33.44	∞	N/A	N/A	N/A	N/A	N/A

Latest BCTX, SALV, COT, PBS, and MTFB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/18/2024	Q2 2024	BCTX BriaCell Therapeutics	-$0.20	-$0.71	-$0.51	-$0.71	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BCTX BriaCell Therapeutics	N/A	N/A	N/A	N/A	N/A
COT Cotinga Pharmaceuticals Inc. (COT.V)	C$0.24	685.71%	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	$0.25	0.60%	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BCTX BriaCell Therapeutics	N/A	2.99	2.99
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	0.05	0.01
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
BCTX BriaCell Therapeutics	15.42%
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A
MTFB MOTIF BIO PLC/S	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A

Insider Ownership

Company	Insider Ownership
BCTX BriaCell Therapeutics	21.77%
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A
MTFB MOTIF BIO PLC/S	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BCTX BriaCell Therapeutics	16	15.98 million	12.50 million	Optionable
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	21.99 million	N/A	Not Optionable
MTFB MOTIF BIO PLC/S	7	N/A	N/A	Not Optionable
PBS Invesco Next Gen Media and Gaming ETF	N/A	720,000	N/A	Not Optionable

BCTX, SALV, COT, PBS, and MTFB Headlines

Source	Headline
	IGPT Invesco AI and Next Gen Software ETF seekingalpha.com - December 16 at 7:25 PM
	"Barbie" Hits $1B at Box Office: Media ETFs on a Roll finance.yahoo.com - August 8 at 11:00 AM
	Media Stocks & ETFs in Focus on "Barbenheimer"s Success finance.yahoo.com - July 24 at 4:14 PM
	ETFs to Add Gains on Netflix Q2 Solid Subscriber Growth finance.yahoo.com - July 20 at 3:20 PM
	These 2 Invesco ETFs Offer Meta Exposure nasdaq.com - April 28 at 12:43 AM
	Invesco Dynamic Media PBS Trading Report marketwatch.com - February 21 at 2:10 PM
	Invesco Dynamic Media ETF declares quarterly distribution of $0.0486 msn.com - December 22 at 6:52 PM
	Invesco Dynamic Energy Exploration & Production ETF declares quarterly distribution of $0.3119 msn.com - December 22 at 1:51 PM
	Invesco Dynamic Building & Construction ETF declares quarterly distribution of $0.0658 msn.com - December 22 at 1:51 PM
	Netflix Returns to Growth, Shares Spike: ETFs to Tap ca.finance.yahoo.com - October 20 at 6:54 AM
	Invesco Dynamic Media ETF declares quarterly distribution of $0.0773 seekingalpha.com - September 20 at 11:04 PM
	Disney Subscriber Base Overtakes Netflix: 5 ETFs to Stream finance.yahoo.com - August 11 at 4:00 PM
	Communication Services ETFs Strengthen as Netflix Adopts Ad-Supported Services nasdaq.com - July 15 at 11:12 PM
	Twitter Share Price Drops After Musk Tries to Renege on Deal nasdaq.com - July 11 at 8:36 PM
	Media ETFs Climb on Buffett’s Berkshire Hathaway Paramount Position finance.yahoo.com - May 21 at 9:26 PM
	Musk’s Twitter Offer Isn’t Enough to Sway Social Media ETFs nasdaq.com - April 14 at 10:56 PM
	Which ETF will benefit most if Elon Musk buys Twitter? seekingalpha.com - April 14 at 12:55 PM
	Twitter’s Proposed Edit Feature Could Rewrite This ETF’s Path nasdaq.com - April 6 at 9:36 PM
	Media, Communication Services ETFs Jump on Elon Musk’s Twitter Holdings nasdaq.com - April 5 at 12:23 AM
	Invesco Dynamic Media ETF declares quarterly distribution of $0.0758 seekingalpha.com - March 23 at 11:55 PM
	New Subscription Tier for Disney+ Should Impact Invesco Funds nasdaq.com - March 4 at 6:26 PM
	Invesco Dynamic Media ETF (PBS) nasdaq.com - January 24 at 6:58 PM
	Analysts Anticipate PBS Will Reach $64 nasdaq.com - January 3 at 9:24 AM
	QUAL, PBS: Big ETF Outflows nasdaq.com - December 10 at 12:54 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BriaCell Therapeutics

NASDAQ:BCTX

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Cotinga Pharmaceuticals Inc. (COT.V)

CVE:COT

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

MOTIF BIO PLC/S

NASDAQ:MTFB

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Invesco Next Gen Media and Gaming ETF

NYSEARCA:PBS

PowerShares Dynamic Media Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Media Intellidex Index (the Index). The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial